PTC Therapeutics Inc (PTCT)
25.21
-0.20
(-0.79%)
USD |
NASDAQ |
Apr 24, 16:00
25.22
+0.01
(+0.04%)
After-Hours: 20:00
PTC Therapeutics Cash from Investing (TTM): -176.74M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -176.74M |
September 30, 2023 | -49.88M |
June 30, 2023 | 116.16M |
March 31, 2023 | 212.17M |
December 31, 2022 | 290.18M |
September 30, 2022 | 326.02M |
June 30, 2022 | 254.28M |
March 31, 2022 | 238.08M |
December 31, 2021 | 219.18M |
September 30, 2021 | -57.21M |
June 30, 2021 | -516.13M |
March 31, 2021 | -430.13M |
December 31, 2020 | -561.55M |
September 30, 2020 | -582.42M |
June 30, 2020 | -157.78M |
March 31, 2020 | -338.01M |
December 31, 2019 | -387.24M |
September 30, 2019 | -182.84M |
June 30, 2019 | -237.38M |
March 31, 2019 | -191.46M |
December 31, 2018 | -42.61M |
September 30, 2018 | -72.06M |
June 30, 2018 | -28.67M |
Date | Value |
---|---|
March 31, 2018 | -12.95M |
December 31, 2017 | 13.12M |
September 30, 2017 | 90.29M |
June 30, 2017 | 109.25M |
March 31, 2017 | 106.78M |
December 31, 2016 | 104.48M |
September 30, 2016 | 29.52M |
June 30, 2016 | -15.00M |
March 31, 2016 | -19.30M |
December 31, 2015 | -20.81M |
September 30, 2015 | -82.17M |
June 30, 2015 | -27.50M |
March 31, 2015 | -120.29M |
December 31, 2014 | -145.17M |
September 30, 2014 | -26.12M |
June 30, 2014 | -196.51M |
March 31, 2014 | -132.08M |
December 31, 2013 | -127.83M |
September 30, 2013 | -133.70M |
June 30, 2013 | -11.69M |
March 31, 2013 | -0.0516M |
December 31, 2012 | -0.189M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-582.42M
Minimum
Sep 2020
326.02M
Maximum
Sep 2022
-106.38M
Average
-157.78M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
Sarepta Therapeutics Inc | -165.80M |
Catalyst Pharmaceuticals Inc | -293.50M |
Pfizer Inc | -32.28B |
Geron Corp | -180.32M |
Perspective Therapeutics Inc | 24.37M |